HealthEquity (HQY)
(Delayed Data from NSDQ)
$90.95 USD
-0.06 (-0.07%)
Updated Aug 6, 2025 04:00 PM ET
After-Market: $90.95 0.00 (0.00%) 5:44 PM ET
3-Hold of 5 3
C Value B Growth A Momentum B VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
HQY 90.95 -0.06(-0.07%)
Will HQY be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for HQY based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for HQY
Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio
Top Stock Reports for Apple, JPMorgan Chase & Visa
HQY: What are Zacks experts saying now?
Zacks Private Portfolio Services
3 Reasons Why Growth Investors Shouldn't Overlook HealthEquity (HQY)
HealthEquity (HQY) is a Top-Ranked Growth Stock: Should You Buy?
HealthEquity (HQY) Upgraded to Buy: Here's Why
Other News for HQY
HealthEquity Announces Dates to Report Second Quarter Earnings and Presentations at Investor ...
ClearBridge Small Cap Fund Q2 2025 Commentary
Fidelity Small Cap Index Fund Q2 2025 Commentary
Fidelity Small Cap Growth Fund Q2 2025 Commentary
Baron Health Care Fund Q2 2025 Shareholder Letter